Concepedia

Michael J. Kemeter

MJ

Statistics

Publications

4

Citations

131

H-Index

4

Active since

2014

Affiliations

Genomic Health (United States)(Current)

Michael J. Kemeter is an author at Genomic Health (United States) specializing in precision medicine, prostate cancer, and oncology.

Publications per year

2014–2018

4

Publications

4

The Impact of a Biopsy Based 17-Gene Genomic Prostate Score on Treatment Recommendations in Men with Newly Diagnosed Clinically Prostate Cancer Who are Candidates for Active Surveillance

Ketan K. Badani, Michael J. Kemeter, Phillip G. Febbo et al. · Urology Practice · 2015 · 55 citations

, , +17

Health Economic Impact and Prospective Clinical Utility of Oncotype DX® Genomic Prostate Score.

David Albala, Michael J. Kemeter, Phillip G. Febbo et al. · PubMed · 2016 · 33 citations · Full text

, , +17

A guide for clinicians in the evaluation of emerging molecular diagnostics for newly diagnosed prostate cancer.

Steven E. Canfield, Adam S. Kibel, Michael J. Kemeter et al. · PubMed · 2014 · 27 citations

, , +17

Improving risk stratification among veterans diagnosed with prostate cancer: impact of the 17-gene prostate score assay.

Julie A. Lynch, Megan Rothney, Raoul Salup et al. · PubMed · 2018 · 16 citations

, , +17

1–4 of 4